"They responded before they had to and provided us with a very aggressive trial"

Status
Not open for further replies.

EJTUNow

Member
Joined
Mar 25, 2013
Messages
28
Reason
Learn about ALS
Country
US
State
North Carolina
City
Carteret
"They responded before they had to and provided us with a very aggressive trial"

Richard Garr, J.D., Director, CEO and President of Neuralstem, expressed particular thanks to the ALS community for their passionate participation in the February 2013 FDA hearing. "The outpouring of support... clearly had an impact which trickled down to the reviewers. They responded before they had to and provided us with a very aggressive trial, which of course is exactly what is needed for this most aggressive disease."

(from ALSWW)

we need more breakthroughs, consider joining us; ALSTUN
 
Status
Not open for further replies.
Back
Top